DEANN L. STOWE N.P.
Prescription History 1952373821
Nurse Practitioner in Springfield, MO
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DEANN L. STOWE N.P., an active Nurse Practitioner specialist practicing in Springfield, MO. Our medical registry currently tracks 7 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 489 documented patient claims. Among these therapy options, the most frequently utilized medication is Prolia, which accounts for 159 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MO PrescribersVs. MO Avg |
|---|---|---|---|
| ProliaDenosumab | 159 | $1,737.88 | ▲ More than typical |
About Prolia: Denosumab is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause (in women), as you age, if someone in your family has osteoporosis, or if you take certain medications (such as prednisone) for long periods. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Denosumab belongs to a class of drugs called monoclonal antibodies. It prevents certain cells in the body (osteoclasts) from breaking down bone. A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS. In 2024, this provider wrote 159 Medicare prescriptions for Prolia, about 7.3 times the volume of the typical Missouri prescriber of this medication (21.9). Medicare paid an average of $1,737.88 per fill, versus $1,724.07 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MO prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 935 30-Day Fills standardized to 30-day supplies 28,050 Days of Medication total across all patients in 2024 | |||
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 86 | $57.37▼ below MO avg | ▲ More than typical |
In 2024, this provider wrote 86 Medicare prescriptions for Ultra-Fine Mini Pen Needle, about 3.8 times the volume of the typical Missouri prescriber of this medication (22.8). Medicare paid an average of $57.37 per fill, versus $87.26 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MO prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MO average for this medication. 247.3 30-Day Fills standardized to 30-day supplies 7,420 Days of Medication total across all patients in 2024 | |||
| Teriparatide | 79 | $2,968.80 | ▲ More than typical |
About Teriparatide: Teriparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication is not recommended for use in children or young adults whose bones are still growing. A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) In 2024, this provider wrote 79 Medicare prescriptions for Teriparatide, about 3.2 times the volume of the typical Missouri prescriber of this medication (24.9). Medicare paid an average of $2,968.80 per fill, versus $2,624.81 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MO prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 95.4 30-Day Fills standardized to 30-day supplies 2,744 Days of Medication total across all patients in 2024 | |||
| ForteoTeriparatide | 52 | $4,983.50 | ▲ More than typical |
About Forteo: Teriparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication is not recommended for use in children or young adults whose bones are still growing. A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) In 2024, this provider wrote 52 Medicare prescriptions for Forteo, about 1.8 times the volume of the typical Missouri prescriber of this medication (29.3). Medicare paid an average of $4,983.50 per fill, versus $4,362.27 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MO prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 59.1 30-Day Fills standardized to 30-day supplies 1,700 Days of Medication total across all patients in 2024 | |||
| TymlosAbaloparatide | 47 | $2,883.28 | ≈ Typical |
About Tymlos: Abaloparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication should not be used for children or young adults whose bones are still growing. Synthetic analog of human PTHrP (Parathyroid Hormone-Related Protein). In 2024, this provider wrote 47 Medicare prescriptions for Tymlos, about the same volume as the typical Missouri prescriber of this medication (45). Medicare paid an average of $2,883.28 per fill, versus $2,737.72 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MO prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 49 30-Day Fills standardized to 30-day supplies 1,470 Days of Medication total across all patients in 2024 | |||
| Alendronate Sodium | 45 | $2.34▼ below MO avg | ≈ Typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2024, this provider wrote 45 Medicare prescriptions for Alendronate Sodium, about 84% of the volume of the typical Missouri prescriber of this medication (53.7). Medicare paid an average of $2.34 per fill, versus $7.33 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MO prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MO average for this medication. 55.8 30-Day Fills standardized to 30-day supplies 1,596 Days of Medication total across all patients in 2024 | |||
| Techlite Pen NeedlePen Needle, Diabetic | 21 | $19.16▼ below MO avg | ≈ Typical |
In 2024, this provider wrote 21 Medicare prescriptions for Techlite Pen Needle, about the same volume as the typical Missouri prescriber of this medication (20). Medicare paid an average of $19.16 per fill, versus $25.62 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MO prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MO average for this medication. 62.3 30-Day Fills standardized to 30-day supplies 1,870 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DEANN L. STOWE N.P. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Nurse Practitioner prescribing approach at this Springfield, MO practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MO prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
